Azenta, Inc. (AZTA)

Market Cap	1.61B
Revenue (ttm)	593.82M
Net Income (ttm)	-59.50M
Shares Out	45.86M
EPS (ttm)	-1.30
PE Ratio	n/a
Forward PE	44.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550,173
Open	35.62
Previous Close	35.60
Day's Range	34.72 - 35.87
52-Week Range	23.91 - 55.64
Beta	1.29
Analysts	Strong Buy
Price Target	43.60 (+24.57%)
Earnings Date	Nov 21, 2025

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 3,300
• Stock Exchange: NASDAQ
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In 2025, Azenta's revenue was $593.82 million, a decrease of -9.52% compared to the previous year's $656.32 million. Losses were -$59.50 million, -63.76% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for AZTA stock is "Strong Buy." The 12-month stock price target is $43.6, which is an increase of 24.57% from the latest price.

Price Target

$43.6

(24.57% upside)

Analyst Consensus: Strong Buy